DRAPER, Utah, Jan. 6, 2014 /PRNewswire/ -- Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to report that it has received a repeat purchase order from one of the world's largest essential oil direct sales distribution companies.
This latest purchase order is for three separate Nutranomics products and constitutes in excess of $240,000 in revenue for the Company. Due to the sensitive and competitive nature of the market, Nutranomics cannot disclose the name of this customer and further details regarding the order.
"As a research and development facility, it's always a positive sign that a product that we have developed gets a repeat order from a customer. It usually means that the market is receiving it well and that customers are getting the results that they are looking for," said Mike Brousseau, General Manager of Nutranomics. "Maintaining and expanding this ongoing relationship will remain a high priority for the Company, and we intend to utilize all of our sales and product development expertise to assist this client in their future growth."
The Company anticipates that all three of these products will continue to be steady sellers for this client in the foreseeable future and that additional product re-orders are probable.
Nutranomics is a publicly traded company engaged in research and development of nutritional food products. In 1997, Nutranomics produced and branded its own product line, and began to sell to the retail outlets and to the public. Nutranomics has also produced formulas for hundreds of other companies. Nutranomics' mission is to increase human health and longevity through education and self-awareness. The Company has sales representatives throughout North America and Asia.
For further information regarding Nutranomics, Inc., please contact our investor relations representatives at firstname.lastname@example.org or call toll-free (888) 616-3999.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements." Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include the Company's expectation that the products mentioned will continue to be steady sellers for the client and that the client will place additional product re-orders. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
SOURCE Nutranomics, Inc.